A best practice emerging from user stories is leveraging AI to research conditions and craft educated questions for healthcare providers. This empowers patients to become better advocates for their own care, improving collaboration with doctors rather than dangerously relying on AI for diagnoses.

Analysis of real-world stories shows people are not using AI for direct medical advice. Instead, the emerging 'best practice' is using LLMs to deeply understand their condition. This empowers them to ask more informed questions to their medical providers, leading to better collaboration and outcomes. AI becomes a tool for patient advocacy, not amateur diagnosis.

While pharmaceutical companies plan to build their own siloed AI chatbots, physicians and patients are already adopting public tools like ChatGPT for clinical communication. This creates a risk of developing redundant solutions that ignore established user behavior.

The next evolution in personalized medicine will be interoperability between personal and clinical AIs. A patient's AI, rich with daily context, will interface with their doctor's AI, trained on clinical data, to create a shared understanding before the human consultation begins.

Patients and providers increasingly use AI agents for advice, but these tools often fail because their underlying data lacks semantic context. To provide relevant, personalized responses instead of generic ones, data must be enriched to understand the patient's specific situation and journey.

The widespread use of AI for health queries is set to change doctor visits. Patients will increasingly arrive with AI-generated analyses of their lab results and symptoms, turning appointments into a three-way consultation between the patient, the doctor, and the AI's findings, potentially improving diagnostic efficiency.

Current medical AI relies on electronic health records, which capture only infrequent snapshots of a person's health. The next breakthrough will come from companies that create new, continuous data rails by engaging with patients longitudinally, generating proprietary "N-of-one" datasets for superior models.

As AI tools increasingly guide patient diagnosis and treatment recommendations, pharma's focus must shift. The primary challenge is no longer just influencing the HCP directly, but ensuring your product data is structured to "win" in the AI's algorithmic suggestions.

A Harvard study revealed that large language models like ChatGPT are not only as or more accurate than doctors in diagnoses but are also preferred by patients for their bedside manner. This suggests AI can fill a crucial empathy and communication gap in modern healthcare.